Eli Lilly's (LLY) Reaction to Disappointing Evacetrapib Data Appears 'Overdone', Says BofA/ML

Go back to Eli Lilly's (LLY) Reaction to Disappointing Evacetrapib Data Appears 'Overdone', Says BofA/ML
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1168.39 +15.46 (1.34%)
Previous Close $1152.93    52 Week High $88.16 
Open $1144.50    52 Week Low $67.88 
Day High $1170.90    P/E 270.46 
Day Low $1134.41    EPS $4.32 
Volume 1,084,708